A major advancement in its mission to revolutionize healthcare has been announced by the medical education platform 30Med. The business is entering a new stage of development and innovation after successfully obtaining a pre-seed funding.
30Med is a startup that aims to transform the way doctors interact with medical education. It was founded by Doctor Ayman Ragab, a visionary entrepreneur with a track record of success in the startup ecosystem. 30Med uses interactive videos and conference events to highlight new medications and promote continuing education. The company’s goal is to close the knowledge gap between physicians and pharmaceutical companies.
A vote of confidence in 30Med’s vision and potential can be seen in this pre-seed fund. It gives the business the resources it needs to advance the development of its platform and increase its visibility in the medical community.
“We are thrilled to announce the successful completion of our pre-seed funding round. This milestone not only validates the importance of our mission but also enables us to accelerate our efforts in transforming medical education,” said Doctor Ayman Ragab, CEO of 30Med.
Apart from obtaining financial support, 30Med has successfully gained significant momentum in the medical field. With a sizable user base, the platform is populated primarily by physicians who are keen to remain up to date on the newest developments in medicine and technology.
Additionally, 30Med’s dedication to changing the face of medical education is demonstrated by its strategic alliances with top pharmaceutical companies in Egypt. 30Med is transforming the way medical information is distributed and accessed by giving pharmaceutical companies a smooth way to present new medications through interactive videos and conference events.
With its goal of enabling doctors to advance their knowledge and stay ahead in the ever-changing healthcare industry, 30Med is unwavering in its endeavours as it grows and changes.
